Delays in the Publication of Important Clinical Trial Findings in Oncology.

ABSTRACT:

Importance

The complete and timely dissemination of clinical trial data is essential to all fields of medicine, with delayed or incomplete data release having potentially deleterious effects on both patient care and scientific inquiry. While prior analyses have noted a substantial lag in the reporting of final clinical study results, we sought to refine these observations through use of a novel starting point for the measurement of dissemination delays: the date of a corporate press release regarding a phase 3 study's results.

Objective

To measure the length of time elapsed between when a sponsor had results of study findings they deemed important to announce, and when the medical community had access to them.

Design and setting

Covering the years 2011 through 2016, w

SUBMITTER: Qunaj L 

PROVIDER: S-EPMC6145729 | biostudies-literature | 2018 Jul

REPOSITORIES: biostudies-literature